Results 121 to 130 of about 65,110 (152)
Some of the next articles are maybe not open access.
Glucagon-like peptide 1 receptor
AfCS-Nature Molecule Pages, 2005Dieter Hoersch +2 more
openaire +1 more source
The Discovery and Development of Glucagon-Like Peptide-1 Receptor Agonists
Current Medicinal ChemistryAbstract: Diabetes mellitus has become a serious life-threatening disease. As one of the new drugs for the treatment of diabetes, GLP-1 receptor agonists have attracted a lot of attention. Compared with traditional hypoglycemic drugs, GLP-1 receptor agonists have good safety and tolerability. To a certain extent, they overcome the problem of the short
Haowen, Fang, Bing, Niu, Qin, Chen
openaire +2 more sources
Glucagon-like peptide-1 receptor agonists
2016Native glucagon-like peptide-1 (GLP-1) is not practical for therapeutic use due to a short half-life caused by ubiquitous, fast, and effective in vivo degradation by the enzyme dipeptidyl peptidase-4 (DPP-4).
openaire +1 more source
The Role of Glucagon-Like Peptide-1 Receptor Agonists in Chronic Obstructive Pulmonary Disease
International Journal of COPD, 2023Jun Chen, Jishun Chen, Hang Qian
exaly
Glucagon-Like Peptide-1 Receptor Agonists and Cancer
JAMA OncologyMahyar, Etminan +2 more
openaire +4 more sources